Quantcast
Viewing all articles
Browse latest Browse all 12727

New study opens door to multipronged attack against skin common cancer

Hailed as a major step forward in the effort to develop targeted cancer therapies, a recently approved drug for the most common type of skin cancer has been a mixed blessing for patients. Although the initial response is usually dramatic, the tumors often recur as the cancer becomes resistant to treatment.

Viewing all articles
Browse latest Browse all 12727

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>